{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:30:28Z","timestamp":1780101028477,"version":"3.54.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"am","delay-in-days":261,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA053443"],"award-info":[{"award-number":["DA053443"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA006420"],"award-info":[{"award-number":["AA006420"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA026999"],"award-info":[{"award-number":["AA026999"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA028549"],"award-info":[{"award-number":["AA028549"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32 AA007456"],"award-info":[{"award-number":["T32 AA007456"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neuropharm.2023.109666","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T21:35:46Z","timestamp":1689543346000},"page":"109666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1841-9139","authenticated-orcid":false,"given":"Jessica M.","family":"Illenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5839-3332","authenticated-orcid":false,"given":"Francisco J.","family":"Flores-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Matzeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-5369","authenticated-orcid":false,"given":"Robert","family":"L\u00fctjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7470-5885","authenticated-orcid":false,"given":"R\u00e9mi","family":"Martin-Fardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109666_bib1","series-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2022"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2023.109666_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2004.06.020","article-title":"Brain substrates for increased drug seeking during protracted withdrawal","volume":"47","author":"Aston-Jones","year":"2004","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2023.109666_bib3","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/npp.2016.107","article-title":"The mGluR2 positive allosteric modulator, AZD8529, and cue-induced relapse to alcohol seeking in rats","volume":"41","author":"Augier","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109666_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pbb.2015.06.004","article-title":"Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II\/III in nucleus accumbens","volume":"135","author":"Baharlouei","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109666_bib5","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1523\/JNEUROSCI.0176-04.2004","article-title":"Preferential effects of the metabotropic glutamate 2\/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer","volume":"24","author":"Baptista","year":"2004","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109666_bib6","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1007\/s12035-018-1318-z","article-title":"Molecular adaptations in the rat dorsal striatum and hippocampus following abstinence-induced incubation of drug seeking after escalated oxycodone-self-administration","volume":"56","author":"Blackwood","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"5115","key":"10.1016\/j.neuropharm.2023.109666_bib7","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1126\/science.8099761","article-title":"Modulation of cocaine self-administration in the rat through D-3 dopamine receptors","volume":"260","author":"Caine","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2023.109666_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00213-002-1283-z","article-title":"A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats","volume":"168","author":"Capriles","year":"2003","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.biopsych.2015.02.018","article-title":"Effect of novel positive allosteric modulator of metabotropic glutamate receptor 2 AZD8529 on incubation of methamphetamine craving after prolonged voluntary abstinence in a rat model","volume":"78","author":"Caprioli","year":"2015","journal-title":"Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109666_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109666_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0166-2236(02)02228-2","article-title":"Cooperation between mglu receptors: a depressing mechanism?","volume":"25","author":"Cho","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109666_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0893-133X(01)00235-4","article-title":"Dissociable effects of antagonism of NMDA and AMPA\/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior","volume":"25","author":"Di Ciano","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109666_bib13","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1021\/acs.jmedchem.6b00913","article-title":"Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)me thyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a selective and orally bioavailable mGlu2 receptor positive allosteric modulator (PAM)","volume":"59","author":"Cid","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1\u20135","key":"10.1016\/j.neuropharm.2023.109666_bib14","doi-asserted-by":"crossref","first-page":"RC89","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000","article-title":"Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction","volume":"20","author":"Cornish","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109666_bib15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0306-4522(99)00214-6","article-title":"A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior","volume":"93","author":"Cornish","year":"1999","journal-title":"Neurosci"},{"issue":"20","key":"10.1016\/j.neuropharm.2023.109666_bib16","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/0006-2952(80)90011-8","article-title":"Suppression of evoked and spontaneous release of neurotransmitters in vivo by morphine","volume":"29","author":"Coutinho-Neito","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.1980.tb14574.x","article-title":"A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant\/dependent rat brain","volume":"68","author":"Fry","year":"1980","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.neuropharm.2023.109666_bib18","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41386-018-0231-5","article-title":"Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats","volume":"43","author":"Gao","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109666_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","article-title":"Glutamatergic substrates of drug addiction and alcoholism","volume":"75","author":"Gass","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109666_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1369-1600.2010.00262.x","article-title":"Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors","volume":"16","author":"Gass","year":"2011","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neubiorev.2009.02.005","article-title":"The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction","volume":"33","author":"Guo","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2023.109666_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90293-3","article-title":"Interactive effects of MK-801and morphine on EEG, EEG power spectra and behavior in rats 1. Morphine tolerance development","volume":"261","author":"Haberny","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2023.109666_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2005.01.072","article-title":"Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats","volume":"1040","author":"Hao","year":"2005","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109666_bib24","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/npp.2010.82","article-title":"The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine seeking and counteracts cocaine-induced enhancement of brain reward function in rats","volume":"35","author":"Jin","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109666_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2015.01.014","article-title":"The novel metabotropic glutamate receptor 2 positive allosteric modulator, AZD8529, decreases nicotine self-administration and relapse in squirrel monkeys","volume":"78","author":"Justinova","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109666_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coph.2003.11.002","article-title":"Glutamate systems in cociane addiction","volume":"4","author":"Kalivas","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109666_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109666_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1301564","article-title":"Drug addiction as a pathology of staged neuroplasticity","volume":"33","author":"Kalivas","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109666_bib29","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109666_bib30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neuron.2005.02.005","article-title":"Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission","volume":"45","author":"Kalivas","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109666_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2008.07.011","article-title":"Glutamate transmission in addiction","volume":"56","author":"Kalivas","year":"2009","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109666_bib32","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.22-09-03306.2002","article-title":"The neuroscience of natural rewards: relevance to addictive drugs","volume":"22","author":"Kelley","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109666_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tips.2004.03.009","article-title":"The ups and downs of addiction: role of metabotropic glutamate receptors","volume":"25","author":"Kenny","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109666_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archpsyc.58.4.334","article-title":"Neural activity related to drug craving in cocaine addiction","volume":"58","author":"Kilts","year":"2001","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109666_bib35","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00213-020-05479-y","article-title":"Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats","volume":"237","author":"Kimbrough","year":"2020","journal-title":"Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109666_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","article-title":"Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement","volume":"87","author":"Koob","year":"2020","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109666_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pharmrev.120.000083","article-title":"Drug addiction: hyperkatifeia\/negative reinforcement as a framework for medications development","volume":"73","author":"Koob","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109666_bib38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular and molecular mechanisms of drug dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2023.109666_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug Abuse: hedonic homeostatic dysregulaion","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2023.109666_bib40","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00213-016-4220-2","article-title":"Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats","volume":"233","author":"Li","year":"2016","journal-title":"Psychopharmacol."},{"issue":"34","key":"10.1016\/j.neuropharm.2023.109666_bib41","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1523\/JNEUROSCI.1766-07.2007","article-title":"Metabotropic glutamate receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence","volume":"27","author":"Liechti","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109666_bib42","first-page":"30","article-title":"Chronic morphine treatment selectively augments metabotropic glutamate receptor-induced inhibition of N-methyl-D-aspartate receptor mediated neurotransmission in nucleus accumbens","volume":"288","author":"Martin","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109666_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/adb.12374","article-title":"Perseveration of craving: effects of stimuli conditioned to drugs of abuse versus conventional reinforcers differing in demand","volume":"22","author":"Martin-Fardon","year":"2017","journal-title":"Addiction Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109666_bib44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/jpet.109.151357","article-title":"Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer","volume":"329","author":"Martin-Fardon","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109666_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107906","article-title":"Targeting the orexin system for prescription opioid use disorder: orexin-1 receptor blockade prevents oxycodone taking and seeking in rats","volume":"164","author":"Matzeu","year":"2020","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109666_bib46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/npp.2017.250","article-title":"Dynorphin counteracts orexin in the paraventricular nucleus of the thalamus: cellular and behavioral evidence","volume":"43","author":"Matzeu","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"21","key":"10.1016\/j.neuropharm.2023.109666_bib47","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1523\/JNEUROSCI.21-21-08655.2001","article-title":"The Circuitry mediating cocaine-induced reinstatement of drug-seeking behavior","volume":"21","author":"McFarland","year":"2001","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109666_bib48","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","article-title":"Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior","volume":"23","author":"McFarland","year":"2003","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109666_bib49","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1523\/JNEUROSCI.4062-12.2013","article-title":"Rescue of Infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence","volume":"33","author":"Meinhardt","year":"2013","journal-title":"J. Neurosci."},{"issue":"27","key":"10.1016\/j.neuropharm.2023.109666_bib50","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","article-title":"Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking","volume":"25","author":"Moran","year":"2005","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109666_bib51","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1073\/pnas.0500914102","article-title":"Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice","volume":"102","author":"Morishima","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109666_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2006.10.010","article-title":"Sex differences and role of gonadal hormones on glutamate level in the nucleus accumbens in morphine tolerant rats: a microdialysis study","volume":"554","author":"Mousavi","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2010.01.030","article-title":"Group II metabotropic glutamate receptors (mGlu2\/3) in drug addiction","volume":"639","author":"Moussawi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib54","first-page":"127","article-title":"\u03949-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions","volume":"151","author":"Nguyen","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109666_bib55","first-page":"297","article-title":"The metabotropic glutamate receptors: structure, activation mechanism and pharmacology","volume":"1","author":"Pin","year":"2002","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.neuropharm.2023.109666_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2018.10.018","article-title":"Downregulation of mGluR2\/3 receptors during morphine withdrawal in rats impairs mGluR2\/3- and NMDA receptor-dependent long-term depression in the nucleus accumbens","volume":"690","author":"Qian","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109666_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1871527311312010017","article-title":"Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets","volume":"12","author":"Rehni","year":"2013","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109666_bib58","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1046\/j.1460-9568.2002.02273.x","article-title":"Metabotropic glutamate receptor 2\/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice","volume":"16","author":"Robbe","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109666_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00498877","article-title":"Supersensitivity of cortical-neurons of rat to acetylcholine and L-glutamate following chronic morphine treatment","volume":"293","author":"Satoh","year":"1976","journal-title":"Naunyn-Schmiedeb Arch Pharmacol"},{"key":"10.1016\/j.neuropharm.2023.109666_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1369-1600.2012.00464.x","article-title":"Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review","volume":"18","author":"Schacht","year":"2013","journal-title":"Addiction Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109666_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00008877-199905000-00001","article-title":"Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence","volume":"10","author":"Schulteis","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2003.10.037","article-title":"Neurochemical changes of the extracellular concentrations of glutamate aspartate in the nucleus accumbens of rats after chronic administration of morphine","volume":"483","author":"Sep\u00falveda","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib63","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1523\/JNEUROSCI.4564-13.2014","article-title":"Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse","volume":"34","author":"Shen","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109666_bib64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0301-0082(00)00033-2","article-title":"Pharmacology and behavioral pharmacoogy of the mesocortical dopamine system","volume":"63","author":"Tzschentke","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib65","series-title":"NSDUH Annual National Report","year":"2020"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109666_bib66","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/npp.2014.188","article-title":"Compulsive-like responding for opioid analgesics in rats with extended access","volume":"40","author":"Wade","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109666_bib67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874473710902020195","article-title":"Phasic dopamine release in appetitive behaviors and drug addiction","volume":"2","author":"Wanat","year":"2009","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neuropharm.2023.109666_bib68","first-page":"398","article-title":"Quantitative aspects of precipitated abstinence in morphine-dependent rats","volume":"184","author":"Wei","year":"1973","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109666_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nn1200","article-title":"Prefrontal responses to drug cues: a neurocognitive analysis","volume":"7","author":"Wilson","year":"2004","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109666_bib70","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/jnr.23025","article-title":"Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal","volume":"90","author":"Wu","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2023.109666_bib71","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11307-021-01586-0","article-title":"Synthesis and characterization of [18F]JNJ-46356479 as the first 18F-labeled PET imaging ligand for metabotropic glutamate receptor 2","volume":"23","author":"Yuan","year":"2021","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.neuropharm.2023.109666_bib72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijdevneu.2004.06.005","article-title":"The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats","volume":"22","author":"Zhu","year":"2004","journal-title":"Int. J. Dev. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:37:02Z","timestamp":1722008222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823002563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":72,"alternative-id":["S0028390823002563"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109666","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109666"}}